ICIs, including programmed cell death protein-1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T cell-associated protein-4 (CTLA-4), kill tumor cells by activating the immune system (Marei et al., 2023). This evidence concerns the gene PDCD1 and neoplasm.